C4 Therapeutics, Inc. (CCCC)
3.865
+0.16
(+4.18%)
USD |
NASDAQ |
Sep 01, 16:00
3.865
0.00 (0.00%)
After-Hours: 19:29
C4 Therapeutics Cash from Operations (Annual) : -98.69M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -98.69M |
| December 31, 2024 | -65.16M |
| December 31, 2023 | -106.84M |
| December 31, 2022 | -105.94M |
| Date | Value |
|---|---|
| December 31, 2021 | -86.96M |
| December 31, 2020 | -67.25M |
| December 31, 2019 | 55.61M |
| December 31, 2018 | -16.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Beam Therapeutics, Inc. | -345.10M |
| Rallybio Corp. | -29.81M |
| Q32 Bio, Inc. | -33.54M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |